NEW YORK (GenomeWeb News) – EraGen Biosciences said today that Inter Medico will act as exclusive distributor for the firm’s molecular diagnostic products in Canada.
Inter Medico is a distributor of tests and other products to clinical labs and hospitals throughout Canada. The firm will distribute several EraGen molecular tests that recently received approval for marketing from Health Canada.
Madison, Wis.-based EraGen recently received Canadian approval to sell molecular diagnostic tests for Bordetella pertussis and parapertussis, enterovirus, influenza types A and B, herpes simplex virus 1 and 2, and cytomegalovirus. The tests run on the firm’s MutliCode RTx real-time PCR system.
EraGen’s entry into the Canadian market "commences our planned expansion into lucrative, rapidly-growing molecular diagnostics markets outside of the United States,” EraGen President and CEO Irene Hrusovsky said in a statement.